Does Butyrophenones Interact with Lidocaine Hydrochloride And Epinephrine Bitartrate?
CDI records a moderate classification for Butyrophenones and Lidocaine Hydrochloride And Epinephrine Bitartrate. The stored summary is: May reduce or reverse pressor effect of epinephrine. Concurrent use should generally be avoided; careful patient monitoring essential if necessary. The mechanism involves reduction/reversal of pressor effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Lidocaine Hydrochloride And Epinephrine Bitartrate Class
- alpha-Adrenergic Agonist
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Reduction/reversal of pressor effect
What To Tell Your Doctor or Pharmacist
If you are taking Butyrophenones and your doctor is considering prescribing Lidocaine Hydrochloride And Epinephrine Bitartrate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider